Home > Healthcare > Pharmaceuticals > Finished Drug Form > North America and Europe PEGylated Drugs Market

North America and Europe PEGylated Drugs Market Share

  • Report ID: GMI2511
  • Published Date: Apr 2018
  • Report Format: PDF

North America and Europe PEGylated Drugs Market Share

Some of the major players of North America PEGylated drugs market are :

  • Merck
  • Shire Group
  • Amgen
  • UCB
  • AstraZeneca
  • Sigma Tau
  • Pfizer
  • Roche
  • Biogen

Prominent players are focusing on R&D activities for developing novel drugs using PEGylation technology for the treatment of chronic diseases to maintain their market position.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of North America and Europe pegylated drugs valued over USD 7.7 billion in 2017.

The industry share of North America and Europe pegylated drugs is expected to witness more than 5% CAGR from 2018 to 2024.

North America & Europe PEGylated Drugs Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2017
  • Companies covered: 10
  • Tables & Figures: 39
  • Countries covered: 6
  • Pages: 100
 Download Free Sample